Hospital La Arruzafa | Cordoba, Spain

Research site
Avenida de la Arruzafa 9, Córdoba, Córdoba, Spain
Site insights

Top conditions

Macular Degeneration (2 trials)

Hereditary Corneal Dystrophies (2 trials)

Geographic Atrophy (2 trials)

Eye Diseases (2 trials)

Graves Ophthalmopathy (2 trials)

Top treatments

VRDN 001

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


5 of 10
Status: Active
Trial type: Interventional
Funder type: Industry

Locations recently updated
A Safety, Tolerability and Efficacy Study of VRDN 001 in Healthy Volunteers and Persons With Thyroid Eye Disease (TED)

Please note that Phase 1/2 (HV & MAD) cohort - recruitment is completed and Phase 3 Component (THRIVE) - is actively recruiting.The investigational d...

Thyroid Eye Disease
Drug: VRDN-001 Phase 3 Cohort (THRIVE)
Drug: VRDN-001 Phase 1/2 MAD (HV and TED)

A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.

Fuchs Endothelial Corneal Dystrophy
Drug: Placebo
Drug: Ripasudil

A phase IIa, open label, non controlled clinical trial to assess the feasibility and safety of allogeneic adipose-derived mesenchymal stem cells (ASC...

Active, not recruiting
Lyell Syndrome
Drug: Double Dose
Drug: Single Dose

The purpose of this clinical study is to evaluate the safety and efficacy of two doses of GT005 administered as a single subretinal injection in subj...

Active, not recruiting
Dry Age-related Macular Degeneration
Drug: GT005; Low Dose
Drug: GT005; High Dose

This is a double-masked, randomized, parallel-assignment, multicenter trial examining the safety and tolerability of teprotumumab in the treatment of...

Active, not recruiting
Thyroid Eye Disease
Drug: Teprotumumab
Drug: Placebo

Trial sponsors

Kowa logo

Kowa (2 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems